Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

217
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
217
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

302
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
302
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Unveiling the endothelialization process of the WATCHMAN FLX Pro: beyond the resolution of conventional imaging.

European heart journal. Cardiovascular Imaging·2026
Same authorSame journal

Donor selection in living-donor lung transplantation for familial pulmonary fibrosis: A narrative review and single-center practical approach.

Respiratory investigation·2026
Same author

Safe and simple pulsed field ablation application using integrated 3D system for AF patients with cardiac tumors.

Indian pacing and electrophysiology journal·2026
Same author

Association Between Osimertinib Dose Reduction and Treatment Outcomes in First-Line EGFR-Mutated Advanced NSCLC: The Impact of Post-Progression Management.

Thoracic cancer·2026
Same author

A Case of Miliary Tuberculosis Complicated by Knee Joint Tuberculosis.

Case reports in infectious diseases·2026
Same author

Atrial Reverse Remodeling by Bachmann's Bundle Pacing With Improved Interatrial Dyssynchrony: Case Series.

Pacing and clinical electrophysiology : PACE·2026

相关实验视频

Updated: Jul 11, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.0K

一年肺功能下降在型硬化症.

Kiminobu Tanizawa1, Tomohiro Handa2, Sonoko Nagai3

  • 1Department of Respiratory Medicine, Japan.

Respiratory investigation
|November 5, 2023
PubMed
概括

萨尔科病患者1年肺功能下降并不能预测死亡率. 然而,肺功能2年下降与沙尔科病的死亡风险增加有关.

关键词:
肺功能 肺功能 肺功能渐进性纤维化的间歇性肺病.渐进的肺纤维化Sarcoidosis 是一种癌症.幸存的生存方式

更多相关视频

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

10.6K
A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation
08:46

A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation

Published on: July 26, 2017

13.3K

相关实验视频

Last Updated: Jul 11, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.0K
Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

10.6K
A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation
08:46

A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation

Published on: July 26, 2017

13.3K

科学领域:

  • 肺部医学 肺部医学
  • 呼吸系统研究 呼吸系统研究

背景情况:

  • 渐进性肺纤维化是由1年的肺功能下降定义的.
  • 对于了解疾病进展来说,研究沙尔科毒症中肺功能变化的研究至关重要.

研究的目的:

  • 为了评估发生和临床意义的1年肺功能下降在萨尔科伊多सिस患者.
  • 为了确定早期肺功能下降是否预测了沙尔科病的长期结果.

主要方法:

  • 在一家专门的沙尔科毒症诊所进行的回顾性观察性研究.
  • 分析肺功能参数,包括强迫生命能力 (FVC) 和一氧化碳 (DLCO) 扩散能力.

主要成果:

  • 18.4%的沙尔科毒症患者经历了一年肺功能下降 (预测FVC≥5%或预测DLCO≥10%).
  • 一年的下降与两年的下降有关 (≥10%的FVC或≥15%的DLCO),在7.4%的患者中观察到.
  • 一年肺功能下降与生存无关,但两年下降预测死亡率.

结论:

  • 一个12个月的肺功能下降不是一个预测者,更糟糕的生存在肉类瘤发病.
  • 长期的肺功能下降 (24 个月) 与沙尔科病的死亡风险增加有关.